Cancer BiologybioRxiv
Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39
The paper develops a platform to monitor CD39 and CD73 enzyme activities in vitro and cell-based assays to aid in drug discovery for cancer immunotherapy.
DOI 10.1371/journal.pone.0220094